NatalizumabDevelopment of anti-drug antibodies and treatment failure: 6 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1897卷 / 1期
关键词：
D O I：
10.1007/s40278-022-11523-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：286 / 286
相关论文
共 50 条
  • [31] anti-drug antibodies and the benefit of assay validation
    Little, Robert
    Sparrow, Miles P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (01) : 194 - 195
  • [32] Anti-drug antibodies in the current management of cancer
    Borregon, Miguel
    Martinez, Katherine
    Ramos, Alba
    Ramos, Irene
    Berzal, Beatriz
    Mazariegos, Manuel
    Martinez, Elia
    Hernandez, Tatiana
    Doger, Bernard
    Moreno, Victor
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (05) : 577 - 584
  • [33] Prediction of natalizumab anti-drug antibodies persistency
    Deisenhammer, Florian
    Jank, Marlies
    Lauren, Anna
    Sjodin, Anders
    Ryner, Malin
    Fogdell-Hahn, Anna
    Sievers, Claudia
    Lindberg, Raija
    Jensen, Poul Erik
    Sellebjerg, Finn
    Christodoulou, Louis
    Birchler, Mary
    Pallardy, Marc
    Auer, Michael
    Liblau, Roland
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 392 - 398
  • [34] InfliximabDevelopment of anti-drug antibodies and paradoxical skin reactions in the form of psoriasis vulgaris and pyoderma gangrenosum: 16 case reports
    Reactions Weekly, 2021, 1836 (1) : 412 - 412
  • [35] Anti-drug antibodies, auto-antibodies and biotherapy in psoriasis
    Jullien, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2012, 139 : S58 - S67
  • [36] Development of an anti-drug antibody assay to detect anti-drug antibodies to protein and PEG in a PEGylated molecule
    Liu, Yanqiu
    Yu, Nancy
    Khosraviani, Mehraban
    Wakshull, Eric
    BIOANALYSIS, 2020, 12 (23) : 1671 - 1679
  • [37] Importance of Determining Anti-drug Antibodies in the Treatment of inflammatory Bowel Disease with Infliximab
    Langmann, Anna
    Langmann, Peter
    INTERNIST, 2019, 60 : S8 - S8
  • [38] Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease
    Steenholdt, C.
    Bendtzen, K.
    Brynskov, J.
    Thomsen, O. O.
    Ainsworth, M. A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S291 - S291
  • [39] Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease
    Steenholdt, Casper
    Bendtzen, Klaus
    Brynskov, Jorn
    Thomsen, Ole
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2014, 146 (05) : S240 - S240
  • [40] Impact of Anti-Drug Antibodies in Preclinical Pharmacokinetic Assessment
    Theingi M. Thway
    Ivan Magana
    Ami Bautista
    Vibha Jawa
    Wen Gu
    Mark Ma
    The AAPS Journal, 2013, 15 : 856 - 863
12345